These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 12840599

  • 1. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
    Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T.
    Am J Nephrol; 2003; 23(4):229-44. PubMed ID: 12840599
    [Abstract] [Full Text] [Related]

  • 2. Disparate effects of calcium antagonists on renal microcirculation.
    Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T.
    Hypertens Res; 1996 Mar; 19(1):31-6. PubMed ID: 8829821
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
    Hayashi K, Wakino S, Homma K, Sugano N, Saruta T.
    J Pharmacol Sci; 2005 Nov; 99(3):221-7. PubMed ID: 16293936
    [Abstract] [Full Text] [Related]

  • 4. Vascular effects of calcium channel antagonists: new evidence.
    Richard S.
    Drugs; 2005 Nov; 65 Suppl 2():1-10. PubMed ID: 16398057
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Saruta T.
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [Abstract] [Full Text] [Related]

  • 7. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.
    Circ Res; 2007 Feb 16; 100(3):342-53. PubMed ID: 17307972
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
    Feng MG, Li M, Navar LG.
    Am J Physiol Renal Physiol; 2004 Feb 16; 286(2):F331-7. PubMed ID: 14583435
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T, Kanno Y, Hayashi K, Konishi K.
    Kidney Int Suppl; 1996 Jun 16; 55():S52-6. PubMed ID: 8743511
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of the renal action of pranidipine in the rat.
    Nagahama T, Hayashi K, Fujiwara K, Ozawa Y, Saruta T.
    Arzneimittelforschung; 2000 Mar 16; 50(3):248-53. PubMed ID: 10758776
    [Abstract] [Full Text] [Related]

  • 14. Benidipine dilates both pre- and post-glomerular arteriole in the canine kidney.
    Yue W, Kimura S, Fujisawa Y, Tian R, Li F, Rahman M, Nishiyama A, Fukui T, Abe Y.
    Hypertens Res; 2001 Jul 16; 24(4):429-36. PubMed ID: 11510756
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II.
    Takenaka T, Suzuki H, Okada H, Inoue T, Kanno Y, Ozawa Y, Hayashi K, Saruta T.
    Kidney Int; 2002 Aug 16; 62(2):558-65. PubMed ID: 12110018
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
    Nakamura M, Notoya M, Kohda Y, Yamashita J, Takashita Y, Gemba M.
    Hypertens Res; 2002 Sep 16; 25(5):751-5. PubMed ID: 12452329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.